En español

Instructions to Principal Investigators Applying for Research Supplements to Promote Diversity in Health-Related Research (Diversity Supplements) at the National Institute on Drug Abuse (NIDA)

The Research Supplements to Promote Diversity in Health-Related Research (or “Diversity Supplements”) program was established by the National Institutes of Health (NIH) to increase the numbers of underrepresented scientists participating in biomedical and behavioral research.  Funding is provided to current NIH research grants to support a minority, disabled, or disadvantaged student or investigator who wants to pursue a career in the biomedical or behavioral research sciences, through research experiences with NIH-funded investigators.

NIDA strongly supports and encourages participation in its diversity supplements program.  Support is available to underrepresented ethnic minority and disabled students and investigators at the undergraduate, predoctoral, postdoctoral, and investigator levels.  For a description of the NIH diversity supplements program, refer to NIH Program Announcement  PA-12-149 “Research Supplements to Promote Diversity in Health-Related Research.”

The diversity supplements program at NIDA is intended to expand the support of underrepresented populations in drug abuse research by providing funding to underrepresented ethnic minority and disabled students and investigators pursuing careers as biomedical or behavioral scientists.  Candidates must not be current recipients of any type of Public Health Service (PHS) funding support at the time of application.  This program may not be used as a replacement funding source for candidates already supported by an NIH grant.

Principal Investigators interested in applying for NIDA diversity supplements should consult with Pamela Goodlow, NIDA Office of Diversity and Health Disparities, prior to submitting an application:  301-443-0441, or e-mail: pg46n@nih.gov.

It is important that applicants follow all instructions in the Application Guide (PHS 398 Application Guide or SF 424 Application Guide, as appropriate) except where instructed to do otherwise in this document, the PA-12-149 PAR, or in a Notice from the NIH Guide for Grants and Contracts.  Electronic submission is highly encouraged.

IMPORTANT: In order to avoid delays in review and funding, NIDA recommends investigators use the following format in preparing applications:

  1. Complete all information on the front (face) page of the appropriate application form. Include the title and grant number of the parent grant, and specify “Diversity Supplement” or “Research Supplements to Promote Diversity in Health-Related Research.”  Signature of the Applicant Organization official with authority to sign grant applications is required.
  2. Page numbers should be inserted on each page of the application, beginning with page 2.
  3. An abstract or summary of the funded parent grant or project must be included.  The abstract page from the funded parent project is preferred.
  4. Provide detailed description (at least 2-4 pages) of the research experience proposed for the proposed candidate.  In this section, include:  1) the actual work and research project proposed for the candidate; 2) discussion of how the proposed research will enhance the candidate’s research capabilities; and, 3) the relationship of the proposed research experience to the overall goals of the parent grant.  Proposed research must fall within the scientific scope of the parent grant.  (Note:  Diversity Supplements may not be used to support new research or research that expands the scientific scope of the funded parent project.)

    It is expected that candidates at the postdoctoral or investigator level give evidence that research proposed during the funding period will enhance research skills and lead directly to careers as independent drug abuse researchers.  Research plan should address specific skills, responsibilities, and activities that demonstrate increasing independence as researchers.  Include timeline for applying for independent research funding.  Funding for candidates at the postdoctoral or investigator level will be limited to two years.
  5. A detailed plan for mentoring the candidate must be included.  Describe mentoring activities (e.g., routine meetings, supervision in writing, publishing; etc.) and support throughout the period of funding, specifying the mentor(s) for each major research activity.
  6. A written timetable for the proposed research experience, outlining the candidate’s major research and development activities by month and year, must be provided.  In this section, include proposed activities that will enhance the research and career development of the candidate (e.g., independent grant submission, publication submission).
  7. A signed statement (1-2 pages) from the proposed candidate, outlining his/her interest in pursuing a long-term career in the research sciences, particularly in some aspect of drug abuse/addiction, must be included.  (Note:  If the candidate is enrolled in a master’s level program, he/she should indicate any plans to enter a Ph.D. or equivalent program.)  A current biographical sketch or curriculum vitae (use “bio sketch” page from SF 424 or the PHS 398 application packet) from the candidate that details education, work experience, science and research experiences, and publications, must be included as well.
  8. Complete contact information for the candidate must be included and should contain permanent e-mail address and telephone number(s).
  9. A copy of the most recent transcript, if the candidate proposed for support is a student at the undergraduate or graduate level, must be provided. Transcripts are not required for postdoctoral or investigator-level candidates.
  10. Proposed budget, using the budget pages from SF 424 or PHS 398 grant application package for proposed initial budget period and future years.  All columns and subheadings (“percentage effort on project,” “fringe benefits,” etc.) must be complete; provide detailed justification for line items such as “supplies” and “other expenses.”
    • Undergraduate: up to $10.00/hr.*
    • Predoctoral: up to $26,000/yr total, for salary, fringe benefits, and/or tuition remission.*
    • Postdoctoral: up to $46,000/yr.*
    • Investigator: up to $60,000/yr.* (note: at least 40% effort on the parent project is required of candidates at the investigator level)
    *For all levels of support, up to $500/yr. may be requested for “general supplies,” and up to $1,500/yr. may be requested for conference/meetings travel.
  11. Enclose a signed statement from the Principal Investigator of the parent grant that verifies the eligibility of the candidate to receive funding through the program based on ethnicity, disability, or disadvantaged status (be specific regarding the category of eligibility and provide further information as needed).  Indicate U.S. citizenship or permanent residency, and any prior PHS research grant support received (note: candidates receiving current PHS funding are not eligible to receive NIH diversity supplements support).
  12. If applicable, documentation that proposed research experience has received approval by Institutional Animal Care and Use Committee (IACUC) or human subjects Institutional Review Board (IRB) should be included.
  13. If candidate is a student or faculty at an institution different from that of the parent grant, a letter from an official at the candidate’s institution indicating support and approval of participation by the candidate with no distraction or interference from his/her studies or professional responsibilities must be included in the application.
  14. Carefully read, fill in page numbers, and insert attached Checklist Page to front of application package before submitting to NIDA.
  15. Send, via one of the following options:
    • Submit SF 424 application electronically via Grants.gov (if submitting electronically, contact Ms. Goodlow of plans to apply electronically prior to submission)
    • E-mail directly to Pamela Goodlow, with application attached in PDF document format;
    • Mail, via Federal Express or overnight mail service, original signed application and two (3) copies;

      Mailed applications should be sent via Federal Express or overnight mail to:

      Pamela Goodlow
      Office of Diversity and Health Disparities
      National Institute on Drug Abuse
      6001 Executive Boulevard
      Room 3105

      Rockville, MD 20852

The following checklist (PDF, 136KB) is to be attached to the front of your original application, before submitting to NIDA:

Pamela Goodlow
Office of Diversity and Health Disparities
National Institute on Drug Abuse
6001 Executive Boulevard
Room 3105
Rockville, MD 20852

This page was last updated March 2014